Letting post-marketing bridge the evidence gap: the case of orphan drugs

    loading  Checking for direct PDF access through Ovid

Abstract

Post-approval studies seldom cover the deficit of knowledge about orphan drugs, find Roberta Joppi and colleagues

Related Topics

    loading  Loading Related Articles